hydroxyindoleacetic acid has been researched along with Cancer, Embryonal in 1 studies
(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This study was conducted to evaluate parameters of serotonin metabolism following platinum-based chemotherapy given in combination with the serotonin type-3 antagonist tropisetron as an antiemetic agent." | 1.29 | Serotonin metabolism following platinum-based chemotherapy combined with the serotonin type-3 antagonist tropisetron. ( de Vries, EG; Groenewegen, A; Kema, IP; Schröder, CP; Sleijfer, DT; van der Graaf, WT, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schröder, CP | 1 |
| van der Graaf, WT | 1 |
| Kema, IP | 1 |
| Groenewegen, A | 1 |
| Sleijfer, DT | 1 |
| de Vries, EG | 1 |
1 other study available for hydroxyindoleacetic acid and Cancer, Embryonal
| Article | Year |
|---|---|
Serotonin metabolism following platinum-based chemotherapy combined with the serotonin type-3 antagonist tropisetron.
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorpromazine; Cispl | 1995 |